Matches in Wikidata for { <http://www.wikidata.org/entity/Q94067962> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q94067962 description "article scientifique publié en 2018" @default.
- Q94067962 description "wetenschappelijk artikel" @default.
- Q94067962 description "наукова стаття" @default.
- Q94067962 name "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 name "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 type Item @default.
- Q94067962 label "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 label "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 prefLabel "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 prefLabel "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 P1433 Q94067962-234CE6C7-89F5-4E51-BD74-D9B1C3CBB2FA @default.
- Q94067962 P1476 Q94067962-1CC45941-37CE-471A-B6D2-EB0EFD7BA5A4 @default.
- Q94067962 P2093 Q94067962-0D8EDEDB-DB11-4232-9731-8F41B7F10B0C @default.
- Q94067962 P2093 Q94067962-11748008-1439-4DEA-903D-F42E247EF764 @default.
- Q94067962 P2093 Q94067962-16089232-B16F-4DAE-9FB7-F613181D2909 @default.
- Q94067962 P2093 Q94067962-21DE1776-51D6-461B-8FBD-E1ECFEEC1A8C @default.
- Q94067962 P2093 Q94067962-22E955E7-4221-488A-86EC-15FAA857F80D @default.
- Q94067962 P2093 Q94067962-63A085E5-EB6C-4747-803D-49846A8E89CC @default.
- Q94067962 P2093 Q94067962-7C65FF83-1EF1-4776-94CD-56F647D95607 @default.
- Q94067962 P2093 Q94067962-821284C2-0776-40DE-927F-8B00184E32A5 @default.
- Q94067962 P2093 Q94067962-9BA857DC-4437-483C-B84A-4C625AA23369 @default.
- Q94067962 P2093 Q94067962-A911A26E-1B66-45A0-8438-1AA056F498F2 @default.
- Q94067962 P2093 Q94067962-AC4CEA1F-0CE4-4A7D-80DA-DD0F83A34C26 @default.
- Q94067962 P2093 Q94067962-B37C87CE-E8B6-4E1D-952A-9D66FA99A8F9 @default.
- Q94067962 P2093 Q94067962-B3E10DD6-68BD-4F67-97BE-4376FA29F2C0 @default.
- Q94067962 P2093 Q94067962-BB801755-AF47-4A3E-9AB1-653F4E92005B @default.
- Q94067962 P2093 Q94067962-BF84A938-EAD3-4246-8F68-BC89C19338EA @default.
- Q94067962 P2093 Q94067962-E28424A2-5E0D-465C-91B9-17636410196A @default.
- Q94067962 P304 Q94067962-9405E259-1153-4711-9182-83CC43F7696B @default.
- Q94067962 P31 Q94067962-A1206CF8-0FA9-4C5B-BD75-C375064542C8 @default.
- Q94067962 P356 Q94067962-9FDEF658-61E3-48A6-9C49-B1F226DBC583 @default.
- Q94067962 P433 Q94067962-4C8285D4-5AF4-4DC1-964A-EBBB50ABF39E @default.
- Q94067962 P478 Q94067962-7E1BC198-CB7C-4B56-BA3C-BFFBC8BD62BB @default.
- Q94067962 P50 Q94067962-115174DB-718B-4669-AB1F-B481240BFCDE @default.
- Q94067962 P577 Q94067962-72D1BB89-AB43-474E-93D4-2197AE94E8AA @default.
- Q94067962 P921 Q94067962-4AB8409F-6E7F-4CC6-ABB5-7D009321E63E @default.
- Q94067962 P921 Q94067962-C3806171-592D-4B5B-ABE3-C0EEC0EBD4E9 @default.
- Q94067962 P932 Q94067962-D1A29369-8049-49E3-AFE7-18B9E1FF2C5B @default.
- Q94067962 P356 NOY059.324 @default.
- Q94067962 P1433 Q15724471 @default.
- Q94067962 P1476 "IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS" @default.
- Q94067962 P2093 "Allison Martin" @default.
- Q94067962 P2093 "Alyssa Reddy" @default.
- Q94067962 P2093 "Asim Bag" @default.
- Q94067962 P2093 "Avi Madan-Swain" @default.
- Q94067962 P2093 "Devang Pastakia" @default.
- Q94067962 P2093 "Diana Osorio" @default.
- Q94067962 P2093 "Gregory Friedman" @default.
- Q94067962 P2093 "James Johnston" @default.
- Q94067962 P2093 "James Markert" @default.
- Q94067962 P2093 "Joshua Bernstock" @default.
- Q94067962 P2093 "Juliette Hukin" @default.
- Q94067962 P2093 "Kara Kachurak" @default.
- Q94067962 P2093 "Matthias Karajannis" @default.
- Q94067962 P2093 "Richard Whitley" @default.
- Q94067962 P2093 "Rong Li" @default.
- Q94067962 P2093 "Yancey Gillespie" @default.
- Q94067962 P304 "i100-i100" @default.
- Q94067962 P31 Q13442814 @default.
- Q94067962 P356 "10.1093/NEUONC/NOY059.324" @default.
- Q94067962 P433 "Suppl 2" @default.
- Q94067962 P478 "20" @default.
- Q94067962 P50 Q92342903 @default.
- Q94067962 P577 "2018-06-22T00:00:00Z" @default.
- Q94067962 P921 Q233309 @default.
- Q94067962 P921 Q5452194 @default.
- Q94067962 P932 "6012830" @default.